FDA Seeks Feedback on Keeping Juice Safe and Clean
Published Date: 2/20/2026
Notice
Summary
The FDA wants to hear from juice makers and importers about their rules for keeping juice safe and clean using special safety checks called HACCP. They’re asking for comments by April 21, 2026, to help decide if they should keep or change these rules. This affects anyone who processes or imports fruit and vegetable juices and helps keep your juice safe without adding extra costs.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
Estimated Recordkeeping Time Burden
FDA estimates the annual recordkeeping burden for this collection is 461,426 hours across respondents, covering an estimated 21,980,369 total records. Examples in FDA's estimate include 1,840 recordkeepers producing 95,680 monitoring-related records and activities that together contribute to the total annual hours.
Juice Processors Must Keep HACCP Records
If you process or import fruit or vegetable juices, you must establish and keep Hazard Analysis and Critical Control Point (HACCP) records under 21 CFR part 120. These records document your HACCP plan, monitoring of critical control points, corrective actions, calibration, validation, and revalidation, and must be retained and presented to FDA upon inspection.
Noncompliance Can Trigger Enforcement
If your juice products or records are not in compliance with applicable statutory and regulatory requirements under the FD&C Act, the products may be considered adulterated and subject to FDA enforcement action. FDA uses HACCP records to determine compliance during inspections.
No Capital or O&M Costs Reported
FDA states there are no capital costs or operating and maintenance (O&M) costs associated with this information collection. The agency reports the burden estimate covers time only and lists no monetary capital or O&M expenses.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11589 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
The FDA has officially placed the combined acoustic and electrical external stimulation device for tinnitus relief into class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification is effective June 10, 2026, with the rules applying retroactively from March 6, 2023.
2026-11578 — Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information
The FDA just gave a thumbs-up to adding bemotrizinol as a new active ingredient in sunscreens, letting it be used up to 6% concentration. This means sunscreen makers can now include this ingredient, which is safe and effective, in their products. The change is official as of June 10, 2026, and could lead to better sun protection options without extra costs for consumers.
Previous / Next Documents
Previous: 2026-03331 — Qualification of Drivers; Exemption Applications; Idiopathic Hypersomnia
The FMCSA got a request from someone with idiopathic hypersomnia, a sleep condition, asking to be allowed to drive big trucks across state lines. If approved, this person can keep working while getting medical treatment, but the public has until March 23, 2026, to share their thoughts. This doesn’t change rules for everyone, just this one case, and there’s no cost impact announced.
Next: 2026-03333 — Agency Information Collection Activities; Proposed Collection; Comment Request; Approved Organizations for Wholesale Drug Distributors and Third-Party Logistics Providers
The FDA wants your thoughts on how it collects info about groups that check and license drug wholesalers and delivery companies. This helps keep medicine safe and the supply chain strong. If you’re involved or interested, send your comments by April 21, 2026—no cost to join, just your voice!